- Home
- /
- News
- /
- Drug Trials
- /
- November 2012
Drug Trials News for November 2012
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber Cancer Institute who led the worldwide clinical trial.
22 November, 2012
A new study has found Acute Myeloid Leukaemia (AML) patients given a new type of 'smart drug' in addition to chemotherapy treatment are 22 percent less likely to relapse and around 13 percent less likely to die from their disease. The results are from a major phase III Cancer Research UK-funded trial led by Cardiff University.
12 November, 2012
An international effort led by researchers at the Perelman School of Medicine at the University of Pennsylvania has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a rare and deadly cholesterol disorder.
02 November, 2012